Gland's Generic Dorzolamide HCL, Timolol Maleate Receives Approval in the U.S.
Gland Pharma's Generic Dorzolamide Hydrochloride Receives Approval in the U.S.
Micro Lab's Generic Dorzolamide Hydrochloride Receives Approval in the U.S.
Dorzolamide Hydrochloride and Tirnolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US$ 80 million for twelve months ending December 2020 according to IQVIA.
Alembic Pharm`s Generic Dorzolamide HCl Receives Approval In US
BASKING RIDGE, N.J., Sept. 25, 2020 /PRNewswire/ -- Micro Labs USA Inc. announces its presence in the US Ophthalmic market of $8.5 billion (source: IQVIA MAT July 2020), by launching two products - Dorzolamide 2% and Dorzolamide-Timolol 22.3-6.8 mg/mL
Micro Lab`s Generic Dorzolamide Hydrochloride Receives Approval in US
Alembic Pharms Generic Dorzolamide Hydrochloride Receives Approval in US
Somerset Therapeutics` Generic Dorzolamide Hydrochloride, Timolol Maleate Receives Approval In US